BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: García-agudo L, Aznar-marín P, Galán-sánchez F, García-martos P, Marín-casanova P, Rodríguez-iglesias M. Otomycosis due to Filamentous Fungi. Mycopathologia 2011;172:307-10. [DOI: 10.1007/s11046-011-9427-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Wang X, Houbraken J, Mei H, Liao W, Hasimu H, Liu W, Deng S. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China. Mycopathologia 2020;185:527-35. [DOI: 10.1007/s11046-020-00448-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Adoubryn K, N’gattia V, Kouadio-yapo G, Nigué L, Zika D, Ouhon J. Épidémiologie des otomycoses au centre hospitalier et universitaire de Yopougon (Abidjan-Côte d’Ivoire). Journal de Mycologie Médicale 2014;24:e9-e15. [DOI: 10.1016/j.mycmed.2013.07.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Kiakojuri K, Mahdavi Omran S, Roodgari S, Taghizadeh Armaki M, Hedayati MT, Shokohi T, Haghani I, Javidnia J, Kermani F, Badali H, Abastabar M. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis. Mycopathologia 2021;186:245-57. [PMID: 33718990 DOI: 10.1007/s11046-021-00537-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kazemi A, Majidinia M, Jaafari A, Ayatollahi Mousavi SA, Zarei Mahmoudabadi A, Alikhah H. Etiologic Agents of Otomycosis in the North-Western Area of Iran. Jundishapur J Microbiol 2015;8:e21776. [PMID: 26495108 DOI: 10.5812/jjm.21776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
5 Hagiwara S, Tamura T, Satoh K, Kamewada H, Nakano M, Shinden S, Yamaguchi H, Makimura K. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan. Mycopathologia 2019;184:13-21. [PMID: 30291485 DOI: 10.1007/s11046-018-0299-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
6 Sabz G, Gharaghani M, Mirhendi H, Ahmadi B, Gatee MA, Sisakht MT, Hemati A, Mohammadi R, Taghavi J, Nouripour-Sisakht S. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent. J Med Microbiol 2019;68:585-90. [PMID: 30801244 DOI: 10.1099/jmm.0.000948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
7 Nemati S, Hassanzadeh R, Khajeh Jahromi S, Delkhosh Nasrollah Abadi A. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol 2014;271:953-7. [PMID: 23595615 DOI: 10.1007/s00405-013-2486-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
8 Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia 2015;179:415-24. [PMID: 25633436 DOI: 10.1007/s11046-015-9864-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
9 Merad Y, Derrar H, Belmokhtar Z, Belkacemi M. Aspergillus Genus and Its Various Human Superficial and Cutaneous Features. Pathogens 2021;10:643. [PMID: 34071092 DOI: 10.3390/pathogens10060643] [Reference Citation Analysis]
10 Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Omran SM. Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol 2015;8:e17138. [PMID: 26060563 DOI: 10.5812/jjm.8(5)2015.17138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Natesan SK, Lamichchane A, Swaminathan S, Wu W. Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus. Diagnostic Microbiology and Infectious Disease 2013;76:458-63. [DOI: 10.1016/j.diagmicrobio.2013.04.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
12 Sangaré I, Amona FM, Ouedraogo RW, Zida A, Ouedraogo MS. Otomycosis in Africa: Epidemiology, diagnosis and treatment. J Mycol Med 2021;31:101115. [PMID: 33516991 DOI: 10.1016/j.mycmed.2021.101115] [Reference Citation Analysis]
13 Zargaran M, Taghipour S, Kiasat N, Aboualigalehdari E, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Shamsizadeh F. Luliconazole, an alternative antifungal agent against Aspergillus terreus. J Mycol Med 2017;27:351-6. [PMID: 28483449 DOI: 10.1016/j.mycmed.2017.04.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
14 Dietl AM, Vahedi-Shahandashti R, Kandelbauer C, Kraak B, Lackner M, Houbraken J, Lass-Flörl C. The Environmental Spread of Aspergillus terreus in Tyrol, Austria. Microorganisms 2021;9:539. [PMID: 33808004 DOI: 10.3390/microorganisms9030539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tasić-Otašević S, Golubović M, Đenić S, Ignjatović A, Stalević M, Momčilović S, Bojanović M, Arsić-Arsenijević V. Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia. J Mycol Med 2020;30:101011. [PMID: 32693980 DOI: 10.1016/j.mycmed.2020.101011] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Powers-fletcher MV, Kendall BA, Griffin AT, Hanson KE, Hayden RT, Wolk DM, Carroll KC, Tang Y. Filamentous Fungi. Microbiol Spectr 2016;4. [DOI: 10.1128/microbiolspec.dmih2-0002-2015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
17 Hubka V, Lyskova P, Frisvad JC, Peterson SW, Skorepova M, Kolarik M. Aspergillus pragensis sp. nov. discovered during molecular reidentification of clinical isolates belonging to Aspergillus section Candidi. Med Mycol 2014;52:565-76. [PMID: 24951723 DOI: 10.1093/mmy/myu022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
18 Swain SK, Behera IC, Sahu MC, Das A. Povidone iodine soaked gelfoam for the treatment of recalcitrant otomycosis - Our experiences at a tertiary care teaching hospital of eastern India. J Mycol Med 2018;28:122-7. [PMID: 29223643 DOI: 10.1016/j.mycmed.2017.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
19 Salari S, Ayatollahi Mousavi SA, Hadizadeh S, Izadi A. Epidemiology of dermatomycoses in Kerman province, southeast of Iran: A 10-years retrospective study (2004-2014). Microb Pathog 2017;110:561-7. [PMID: 28757272 DOI: 10.1016/j.micpath.2017.07.043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
20 Aboutalebian S, Mahmoudi S, Mirhendi H, Okhovat A, Abtahi H, Chabavizadeh J. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents. J Med Microbiol 2019;68:918-23. [PMID: 31063125 DOI: 10.1099/jmm.0.000985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 Jing R, Yang WH, Xiao M, Li Y, Zou GL, Wang CY, Li XW, Xu YC, Hsueh PR. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China. J Microbiol Immunol Infect 2021:S1684-1182(21)00063-3. [PMID: 33839057 DOI: 10.1016/j.jmii.2021.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]